Karo Bio Acquires Product for Treatment of Common Cold
Regulatory News: Karo Bio (STO:KARO) has signed an agreement to acquire the drug research company Tanomed AB, which has developed a unique product for common cold. The acquisition provides Karo Bio access to a new product to …